Features of endoscopic procedure site reaction associated with a recently approved submucosal lifting agent.
Journal
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
ISSN: 1530-0285
Titre abrégé: Mod Pathol
Pays: United States
ID NLM: 8806605
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
received:
06
01
2020
accepted:
18
02
2020
revised:
18
02
2020
pubmed:
4
3
2020
medline:
9
7
2021
entrez:
4
3
2020
Statut:
ppublish
Résumé
Endoscopic resection techniques, such as endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD), are frequently aided by injection of submucosal lifting solutions that create a plane for dissection and protect deeper mural layers. ORISE™ gel is a recently approved synthetic lifting solution that produces a localized inflammatory reaction associated with retained gel at the injection site. We describe a series of six cases of ORISE™-associated inflammatory lesions in patients who underwent endoscopic resections. Deposits comprised pale fibrillary or hyalinized eosinophilic material, depending on their age. All cases were associated with an inflammatory reaction composed of foreign-body giant cells and scattered eosinophils. ORISE™ gel extended laterally and deeply beyond residual tumors in all cases. Histochemically, the material proved to be negative for Congo Red, and mucicarmine, faint blue with Alcian blue, but positive for PAS and PAS-D. It stained blue with trichrome. Such deposits were absent in cases, wherein other widely-available lifting solutions were used. We compared ORISE™ deposits to histologically similar extracellular deposits, namely amyloid and pulse granulomata. Unlike ORISE™ material, amyloid deposits appear as waxy, more densely eosinophilic material, and stain positive with Congo Red. Amyloid demonstrated prominent intramucosal and perivascular distributions, features not seen in this series of ORISE™ deposits. Hyalinized pulse granulomata showed strong overlap with ORISE™ deposits, since they also comprise eosinophilic material associated with giant cell reaction. On the other hand, they form ribbons of glassy material in circumscribed lobules, unlike the ill-defined ORISE™ deposits. In summary, we describe the pathologic findings at injection sites in patients who underwent endoscopic procedures aided by the recently approved lifting agent, ORISE™. Pathologists should be aware of its appearance and associated reaction to avoid confusion with other common extracellular deposits seen in the gastrointestinal tract.
Identifiants
pubmed: 32123304
doi: 10.1038/s41379-020-0509-0
pii: S0893-3952(22)00801-8
doi:
Substances chimiques
Amyloid
0
Gels
0
Polymers
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
1581-1588Subventions
Organisme : NCI NIH HHS
ID : P30 CA013330
Pays : United States
Références
Hwang JH, Konda V, Abu Dayyeh BK, Chauhan SS, Enestvedt BK, Fujii-Lau LL, et al. Endoscopic mucosal resection. Gastrointest Endosc 2015;82:215–26.
doi: 10.1016/j.gie.2015.05.001
Kantsevoy SV, Adler DG, Conway JD, Diehl DL, Farraye FA, Kwon R, et al. Endoscopic mucosal resection and endoscopic submucosal dissection. Gastrointest Endosc 2008;68:11–18.
doi: 10.1016/j.gie.2008.01.037
Ferlitsch M, Moss A, Hassan C, Bhandari P, Dumonceau JM, Paspatis G, et al. Colorectal polypectomy and endoscopic mucosal resection (EMR): European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline. Endoscopy 2017;49:270–97.
doi: 10.1055/s-0043-102569
Burke C, Kaul V, Pohl H. Polyp resection and removal procedures: insights from the 2017 digestive disease week. Gastroenterol Hepatol (NY). 2017;13 Suppl 2:1–24.
Wallace MB. New strategies to improve polypectomy during colonoscopy. Gastroenterol Hepatol (NY). 2017;13(10 Suppl 3):1–12.
Vogel JD, Eskicioglu C, Weiser MR, Feingold DL, Steele SR. The American Society of colon and rectal surgeons clinical practice guidelines for the treatment of colon cancer. Dis Colon Rectum. 2017;60:999–1017.
doi: 10.1097/DCR.0000000000000926
Holmes I, Friedland S. Endoscopic mucosal resection versus endoscopic submucosal dissection for large polyps: a western colonoscopist’s view. Clin Endosc 2016;49:454–6.
doi: 10.5946/ce.2016.077
Johnson DA, Wallace MB, Kaul V, Kaltenbach T. Incomplete resection rates in polyps smaller than 2 centimeters. Proceedings from a live clinical roundtable held during digestive disease week. Gastroenterol Hepatol (NY). 2018;14 Suppl 5:1–19.
Castro R, Libânio D, Pita I, Dinis-Ribeiro M. Solutions for submucosal injection: what to choose and how to do it. World J Gastroenterol. 2019;25:777–88.
doi: 10.3748/wjg.v25.i7.777
Ferreira AO, Moleiro J, Torres J, Dinis-Ribeiro M. Solutions for submucosal injection in endoscopic resection: a systematic review and meta-analysis. Endosc Int Open. 2016;4:E1–E16.
pubmed: 26793777
ORISE™. ORISE™ Gel. Gel Submucosal Lifting Agent. Boston Scientific Corporation. 2019 https://www.bostonscientific.com/content/gwc/en-US/products/lifting-agents/orise-gel.html .
World Health Organization (WHO). Classification of tumours editorial board. Digestive system tumours. 5th ed. Lyon, France: International Agency for Research on Cancer; 2019. p. 635.
Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, et al. AJCC cancer staging manual. 8th ed. New York: Springer International Publishing; 2017.
Westbrook LM, Henn PA, Cornish TC. Lifting agent granuloma. Am J Clin Pathol. 2019. pii: aqz204. https://doi.org/10.1093/ajcp/aqz204 . [Epub ahead of print].
Pezhouh MK, Burgart LJ, Chiu K, Cohen DA, Hutchings DA, Sanderson SO, et al. Characterization of novel injectable lifting agents used in colonic polyp removal: an emerging amyloid mimic. Am J Surg Pathol. 2020. https://doi.org/10.1097/PAS.0000000000001435 . [Epub ahead of print].
Iida T, Yamano H, Nakase H. Systemic amyloidosis with gastrointestinal involvement: diagnosis from endoscopic and histological views. J Gastroenterol Hepatol. 2018;33:583–90.
doi: 10.1111/jgh.13996
Sipe JD, Benson MD, Buxbaum JN, Ikeda S, Merlini G, Saraiva MJ, et al. Nomenclature 2014: amyloid fibril proteins and clinical classification of the amyloidosis. Amyloid. 2014;21:221–4.
doi: 10.3109/13506129.2014.964858
Freudenthaler S, Hegenbart U, Schönland S, Behrens HM, Krüger S, Röcken C. Amyloid in biopsies of the gastrointestinal tract-a retrospective observational study on 542 patients. Virchows Arch. 2016;468:569–77.
doi: 10.1007/s00428-016-1916-y
Oyasiji T, Yood S. Jejunal amyloidoma—a rare cause of gastrointestinal bleeding. Cases J 2009;2:9100.
doi: 10.1186/1757-1626-2-9100
Nowacki NB, Arnold MA, Frankel WL, Harzman A, Limketkai BN, Yearsley MM, et al. Gastrointestinal tract-derived pulse granulomata: clues to an underrecognized pseudotumor. Am J Surg Pathol. 2015;39:84–92.
doi: 10.1097/PAS.0000000000000308
Gonzalez RS. Incidence of pulse granuloma in the small and large intestines. Am J Surg Pathol. 2016;40:137–40.
doi: 10.1097/PAS.0000000000000572
Ban S, Fujii A, Takimoto T, Kikuchi K, Kang W, Namiki Y, et al. Pulse granulomas in interval appendectomy specimens: histochemical identification of cellulose matter. Case Rep Gastroenterol. 2018;12:765–72.
doi: 10.1159/000495318
Deroche TC, Gates GA, Huber AR. Pulse granulomas of the gastrointestinal tract and gallbladder: report of five cases. Case Rep Pathol. 2017;2017:2497945.
pubmed: 28785500
pmcid: 5530411
Gupta A, Lyapichev K, Rojas CP. Pulse granuloma of the rectum: an unusual entity. Histopathology. 2016;68:938–9.
doi: 10.1111/his.12875
Philipsen HP, Reichart PA. Pulse or hyaline ring granuloma. Review of the literature on etiopathogenesis of oral and extraoral lesions. Clin Oral Investig. 2010;14:121–8.
doi: 10.1007/s00784-009-0322-0
Kotrashetti VS, Angadi PV, Mane DR, Hallikerimath SR. Oral pulse granuloma associated with keratocystic odontogenic tumor: report of a case and review on etiopathogenesis. Ann Maxillofac Surg. 2011;1:83–6.
doi: 10.4103/2231-0746.83153